Final answer:
Giving too much pyridostigmine can lead to a cholinergic crisis, while giving too little can worsen the symptoms of Myasthenia Gravis.
Step-by-step explanation:
Pyridostigmine (Mestinon) is a medication commonly used to treat Myasthenia Gravis, an autoimmune disorder that causes muscle weakness. If too much pyridostigmine is given, it can lead to a cholinergic crisis, which is characterized by excessive stimulation of the muscarinic and nicotinic receptors. Symptoms of a cholinergic crisis include muscle twitching, sweating, nausea, and increased weakness.
On the other hand, if too little pyridostigmine is given, the symptoms of Myasthenia Gravis may worsen and the patient may experience increased muscle weakness, fatigue, and difficulty in performing everyday tasks.
It is important for patients with Myasthenia Gravis to work closely with their healthcare provider to determine the appropriate dosage of pyridostigmine to balance symptom improvement and minimize side effects.